| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.08. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 23.07. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.06. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.06. | Allurion enacts 1-for-15 reverse stock split for exchange relisting | 2 | Seeking Alpha | ||
| 17.06. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.06. | Allurion Technologies, Inc. Advances Plan to Re-List / Announces a 1-for-15 reverse stock split | 242 | Business Wire | NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (OTCQB: ALUR), a pioneer in metabolically healthy weight loss, today announced a 1-for-15 reverse stock of its outstanding common stock intended... ► Artikel lesen | |
| 27.05. | ALLURION TECHNOLOGIES, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| ALLURION TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 30.03. | ALLURION TECHNOLOGIES, INC. - 10-K, Annual Report | - | SEC Filings | ||
| 06.03. | NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) | 355 | Business Wire | NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange ("NYSE", the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities... ► Artikel lesen | |
| 02.03. | Allurion Technologies, Inc. Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE | 272 | Business Wire | Company's recent FDA approval catalyzes plan to regain compliance with listing requirements of NYSE or another exchange; shares of common stock expected to continue trading on NYSE during appeal process
NATICK... ► Artikel lesen | |
| 02.03. | NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR) | 221 | Business Wire | NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange ("NYSE", the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities... ► Artikel lesen | |
| 27.02. | Weekly Buzz: MacroGenics' LINNET Trial On Hold; Eton Pharmaceuticals, Allurion Technologies Get FDA Nod; Gilead Sciences Snaps Up Arcellx | 1.491 | AFX News | FOSTER CITY (dpa-AFX) - This week, the biotech space witnessed significant milestones, including FDA approvals, oncology drug acquisitions, and collaborations. Positive clinical trial results... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,170 | 0,00 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| GERRESHEIMER | 26,040 | -0,53 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
19.09.2026 / 08:53 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| NETRAMARK | 0,435 | -3,33 % | NetraMark Holdings Inc.: NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness | TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence company transforming clinical... ► Artikel lesen | |
| NANO-X IMAGING | 0,641 | +0,17 % | Nano-X Imaging Ltd: Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica | Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative... ► Artikel lesen | |
| VAREX IMAGING | 16,300 | +0,62 % | Teledyne To Buy Varex Imaging For About $1.1 Bln In Cash | WASHINGTON (dpa-AFX) - Teledyne Technologies Inc. (TDY) announced on Monday that it has agreed to buy Varex Imaging Corp. (VREX) for $18.90 per share in cash, valuing the deal at about $1.1... ► Artikel lesen | |
| FRESENIUS | 46,150 | +0,91 % | EQS-News: mAbxience und Sandoz unterzeichnen Kooperationsvereinbarung zur weltweiten Förderung des Zugangs zu Biosimilars | EQS-News: mAbxience
/ Schlagwort(e): Vereinbarung/Sonstiges
mAbxience und Sandoz unterzeichnen Kooperationsvereinbarung zur weltweiten Förderung des Zugangs zu Biosimilars
19.09.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,790 | +1,56 % | Siemens Healthineers Aktie: Unscharfes Selbstbild - Warren Wise Podcast | Scharfe Bilder für andere, ein unscharfes Bild von sich selbst. Siemens Healthineers baut die Technik, mit der Ärzte Krankheiten erkennen, sichtbar machen und behandeln - vom Bluttest über den großen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,800 | +1,14 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,215 | +0,06 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,410 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 56,61 | +0,04 % | Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve? | ||
| FIREFLY NEUROSCIENCE | 2,020 | +0,50 % | Firefly Neuroscience und NeuroSigma kooperieren bei ADHS-Behandlung | ||
| LIFESTANCE HEALTH GROUP | 11,835 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 17,190 | -0,06 % | Procept BioRobotics verlängert Kreditlaufzeit mit CIBC um ein Jahr | ||
| CARL ZEISS MEDITEC | 31,060 | -1,52 % | Aktien KW 38 Warsh konnte nicht bremsen. Iran verhindert mehr. TACO gefragt! News. Rheinmetall. Mutares. Verbio. Lufthansa. Hapag Lloyd. Carl Zeiss MediTec. Verbio. BASF. DEFAMA. Vonovia. Aroundtown. SFC Energy. Dürr. Evonik. Continental. Elmos Semiconduc | Aktien - es gab eine Leitzinserhöhung in den USA. Da von allen erwartet konnten die Aktienmärkte damit relativ gut umgehen. Selbst Gold und Silber atmeten einmal kurz ein udn setzten danach zum neuen... ► Artikel lesen |